Journey Medical (DERM) Accumulated Expenses (2020 - 2026)
Journey Medical (DERM) posted Accumulated Expenses of $390000.0 for Q1 2026, down 54.12% on a QoQ basis from $850000.0 in Q4 2025, and down 98.31% year-over-year from $23.0 million in Q1 2025.
Journey Medical (DERM) Accumulated Expenses (2020 - 2026) Analysis & Trends
Journey Medical's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $390000.0 for Q1 2026.
- Quarterly Accumulated Expenses fell 98.31% year-over-year to $390000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $390000.0 (down 98.31% YoY) and the FY2025 annual result came in at $850000.0, up 110.4% from the prior year.
- Accumulated Expenses was $390000.0 for Q1 2026 at Journey Medical, down from $850000.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $23.0 million in Q1 2025 and bottomed at $22000.0 in Q4 2023.
- A 5-year average of $4.5 million and a median of $850000.0 in 2025 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses tumbled 99.52% — and 2023, when it soared 2580.52%.
- Journey Medical's Accumulated Expenses stood at $2.6 million in 2022, then sank by 99.15% to $22000.0 in 2023, then soared by 1736.36% to $404000.0 in 2024, then surged by 110.4% to $850000.0 in 2025, then plunged by 54.12% to $390000.0 in 2026.
- Business Quant data shows DERM's Accumulated Expenses at $390000.0 in Q1 2026, $850000.0 in Q4 2025, and $995000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 390,000.00 |
| Dec 31, 2025 | 850,000.00 |
| Sep 30, 2025 | 995,000.00 |
| Jun 30, 2025 | 416,000.00 |
| Mar 31, 2025 | 23.01 Mn |
| Dec 31, 2024 | 404,000.00 |
| Sep 30, 2024 | 332,000.00 |
| Jun 30, 2024 | 251,000.00 |
| Mar 31, 2024 | 20.03 Mn |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Mar 31, 2023 | 17.38 Mn |
| Dec 31, 2022 | 2.59 Mn |
| Sep 30, 2022 | 125,000.00 |
| Jun 30, 2022 | 77,000.00 |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 229,000.00 |
| Sep 30, 2021 | 26.05 Mn |
| Dec 31, 2020 | 21.50 Mn |